Saturday 17 October 2026
Export TIL’s income statement to Excel — free account
Instil Bio, Inc.
In the quarter to June 2026, EPS grew 80.6%, free cash flow grew 68.6% and total debt was flat, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
5.91
0.22
−3.59%
Follow TIL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | — | — |
P/S ratio |
— | — | — | — | — | 3,065.12 | — | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | 3.50 | — | — |
P/FCF ratio |
— | — | — | — | — | 0.00 | — | — |
P/Operating CF |
— | — | — | — | — | (25.14) | — | — |
P/B ratio |
— | — | — | — | — | 0.00 | — | — |
Price to Tangible BV |
— | — | — | — | — | 0.00 | — | — |
EV/Sales |
— | — | — | — | — | 1,313.57 | — | — |
EV/EBITDA |
— | — | — | — | — | 0.00 | — | — |
EV/Operating CF |
— | — | — | — | — | (6.12) | — | — |
EV/FCF |
— | — | — | — | — | (2.25) | — | — |
Quick Ratio |
15.75 | 14.58 | 14.38 | 7.96 | 10.98 | 18.20 | 6.26 | — |
Current Ratio |
39.53 | 15.76 | 15.22 | 8.22 | 11.22 | 18.53 | 6.54 | — |
Net Debt/EBITDA |
(0.11) | 0.44 | 0.46 | 0.92 | 2.97 | 7.24 | 1.35 | — |
Debt/Assets |
41.67% | 31.94% | 25.01% | 15.01% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.74 | 0.50 | 0.36 | 0.20 | 0.00 | 0.00 | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.51 | 0.75 | 0.53 | 0.81 | 0.78 | 0.78 | 0.81 | — |
Capex/Depreciation |
0.00 | 0.00 | (4.34) | (3.88) | (21.01) | (198.50) | (10.50) | — |
Interest Coverage |
(13.48) | (8.18) | (30.56) | (120.26) | — | (480.63) | (96.84) | — |
| (50.39%) | (37.51%) | (52.96%) | (48.58%) | (60.82%) | 162.35% | 28.06% | — | |
| (30.56%) | (25.16%) | (38.65%) | (40.87%) | (33.76%) | (22.98%) | (137.65%) | — | |
ROIC |
(40.13%) | (33.19%) | (64.02%) | (80.86%) | (96.17%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(38.23%) | (30.14%) | (54.03%) | (51.49%) | (28.79%) | (13.09%) | (80.96%) | — |
Average Days of Receivables |
— | — | — | — | — | 0.00 | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 14,057.25% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10,422.46% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,236.23% | 0.00% | — |
Graham Net Nets |
— | — | — | — | — | (0.27) | — | — |
Graham Number |
— | — | — | — | — | 229.24 | — | — |
Earnings Yield |
— | — | — | — | — | (8.92%) | — | — |
Free Cash Flow Yield |
— | — | — | — | — | (19.02%) | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | — |
Operating CF per Share |
(5.49) | (8.56) | (12.61) | (27.82) | (23.05) | (37.02) | (8.93) | — |
Capex per Share |
0.00 | 0.00 | (3.18) | (13.06) | (10.91) | (63.53) | (0.35) | — |
Free Cash Flow per Share |
(5.49) | (8.56) | (15.79) | (40.88) | (33.96) | (100.55) | (9.29) | — |
Cash per Share |
11.44 | 17.69 | 23.35 | 40.29 | 85.68 | 302.18 | 15.02 | — |
Shareholders Equity per Share |
17.08 | 26.03 | 34.72 | 56.15 | 104.76 | (49.50) | (11.63) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
17.08 | 26.03 | 34.72 | 56.15 | 104.76 | (49.50) | (11.63) | — |
Free Cash Flow |
(36.62) | (55.70) | (102.69) | (264.75) | (179.97) | (80.43) | (5.50) | — |
Working Capital |
186.59 | 116.57 | 150.20 | 236.59 | 422.66 | 232.86 | 7.87 | — |
Capital Expenditures |
— | — | (20.66) | (84.59) | (57.83) | (50.82) | (0.21) | — |
Net Current Asset Value |
101.77 | 30.34 | 60.96 | 150.86 | 409.24 | (112.47) | (7.08) | — |
EV/EBIT |
— | — | — | — | — | 0.00 | — | — |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 368.23 | 0.00 | — |
Price to Operating Income |
— | — | — | — | — | 0.00 | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
4.24 | 0.03 | 0.03 | 0.11 | 0.02 | 0.00 | 0.11 | — |
Cash ROIC |
(13.32%) | (15.10%) | (22.37%) | (37.99%) | (17.83%) | (39.80%) | (274.74%) | — |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | 0.00 | — |
Average Payables |
0.72 | 0.94 | 1.79 | 3.96 | 4.53 | 2.24 | 2.24 | — |
Average Assets |
233.55 | 294.60 | 403.88 | 546.06 | 464.50 | 164.24 | 4.74 | — |
Average Common Equity |
141.65 | 197.63 | 294.72 | 459.40 | 257.80 | (23.25) | (23.25) | — |
Columns are period end dates